The growing prevalence of opioid use disorders (OUDs) in the community and in Criminal Justice Systems drives increasing rates of overdose mortality, poor health, and high costs. Persons incarcerated in local jails and prisons are particularly susceptible to increased risk of unintentional overdose, re-incarceration, and uncontrolled HIV. Methadone maintenance treatment is effective community treatment for OUD. However, the impact of methadone maintenance offered routinely in a large, high-volume, high-turnover municipal jail setting has not been studied. New York City, with a large jail methadone program, a jail electronic medical record, and a rich collection of regional health surveillance databases, presents a unique opportunity to estimate in-jail methadone treatment and associations with post-release overdose, re-incarceration, HIV control, and costs. This study analyses important opioid-related outcomes among NYC jail inmates admitted to and leaving NYC jails during 2011-2017, and compares individuals who: a) accessed the jail methadone maintenance treatment program and were released from jail on methadone maintenance, or, b) were diagnosed with an opioid use disorder but did not access methadone and were released from jail out- of-treatment (detox-only). Secondary, exploratory analysis will examine outcomes among, c) a smaller sample of buprenorphine maintained individuals. We will test the primary hypotheses that methadone maintenance exposure reduced the risk of fatal and non-fatal overdoses and jail recidivism, improved HIV control (among HIV-positive persons), and improved rates of appropriate health care utilization and lowered costs. This study proposes to link New York City jail electronic medical records with NYC-wide overdose, re-incarceration, HIV/AIDS, and related health and economic outcome data to better define the public health impact of methadone maintenance in NYC jails.

Public Health Relevance

The current US opioid and overdose epidemic disproportionately involves Criminal Justice Systems, in which dramatic increases in overdose deaths, poor health and HIV outcomes, and high costs routinely follow release from jails and prisons. In NYC, a large in-jail methadone program treats adult men and women since the 1980?s, providing a unique opportunity to examine the effects of methadone maintenance on overdose, health, and costs upon release back to the community. The goal of this study is to link NYC jail electronic medical records to NYC-wide longitudinal community health datasets in order to understand the effects in-jail of methadone maintenance on post-release overdose, recidivism, HIV control, and costs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA045042-03
Application #
9930577
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mulford, Carrie Fried
Project Start
2018-08-15
Project End
2023-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016